Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01049334 · ClinicalTrials.gov registry record · Phase 3
A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis
A Phase 3 study, sponsored by Reckitt Benckiser.
- Completed
- Registry status
- Phase 3
- Development phase
- 204
- Enrollment target
NCT01049334 is a Phase 3 study that has completed, run by Reckitt Benckiser. The registered enrollment target is 204 participants.
The verdict
NCT01049334, a Phase 3 study, has completed, sponsored by Reckitt Benckiser.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 204 participants
- Enrollment target
Study Summary
The purposes of this study is to demonstrate the analgesic efficacy of flurbiprofen 8.75 mg lozenge compared to its vehicle lozenge and to demonstrate the safety of the flurbiprofen lozenge throughout the course of treating sore throat due to acute pharyngitis.
Interventions
- DRUG Placebo
- DRUG Flurbiprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01049334
The ClinicalTrials.gov registry entry for NCT01049334 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reckitt Benckiser, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01049334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01049334 about?
NCT01049334 is a clinical study titled "A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis". The purposes of this study is to demonstrate the analgesic efficacy of flurbiprofen 8.75 mg lozenge compared to its vehicle lozenge and to demonstrate the safety of the flurbiprofen lozenge throughout the course of treating sore throat due to acute pharyngitis.
What is the current status of trial NCT01049334?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 204 participants. The study started on 2009-11. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01049334?
The interventions under investigation include: Placebo (DRUG), Flurbiprofen (DRUG).
Who is sponsoring clinical trial NCT01049334?
This trial is sponsored by Reckitt Benckiser, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.